The FDA recently approved the Janus kinase (JAK) inhibitor ritlecitinib (Litfulo) for adults and adolescents with severe alopecia areata. It is, so far, the only treatment approved by the FDA… read more.
People who suffer long-term consequences of Covid-19 can experience a wide range of symptoms. As the precise nature and duration of Long Covid is still being untangled by… read more.
A report of nine cases of alopecia areata (AA) following SARS-CoV-2 vaccination appears to confirm suspicions that mRNA vaccines can trigger autoimmune responses that lead to hair loss…. read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
